ibandronic acid has been researched along with Muscular Atrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brennan-Speranza, TC; Duque, G; Hayes, A; Levinger, I; Lin, X; Moreno-Asso, A; Smith, C; Zarekookandeh, N | 1 |
| Fujita, N; Kobayashi, T; Matsumoto, M; Matsumoto, Y; Miyamoto, K; Miyamoto, T; Morita, M; Nakamura, M; Oike, T; Sato, Y; Takeda, S; Watanabe, R | 1 |
2 other study(ies) available for ibandronic acid and Muscular Atrophy
| Article | Year |
|---|---|
Undercarboxylated osteocalcin and ibandronate combination ameliorates hindlimb immobilization-induced muscle wasting.
Topics: Aged; Animals; Glucose; Hindlimb Suspension; Humans; Ibandronic Acid; Insulin; Insulin Resistance; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Atrophy; Osteocalcin; Proto-Oncogene Proteins c-akt | 2023 |
Ibandronate concomitantly blocks immobilization-induced bone and muscle atrophy.
Topics: Animals; Bone Density Conservation Agents; Bone Resorption; Cell Line; Diphosphonates; Dose-Response Relationship, Drug; Female; Ibandronic Acid; Immobilization; Mice; Mice, Inbred C57BL; Muscular Atrophy; Organ Size; Proteasome Endopeptidase Complex; Treatment Outcome; Ubiquitination | 2016 |